Suchergebnisse - "Xing, Cheng"

PubPharm (417)

51

An Evolving Role of Aqueous Piperazine to Improve the Solubility of Non-Steroidal Anti-Inflammatory Drugs

enthalten in: Journal of pharmaceutical sciences | 2022

von Fang, Z. | Zhang, B. | Xing, W. | +5

52

Polyaniline-MXene-coated carbon cloth as an anode for microbial fuel cells

enthalten in: Journal of solid state electrochemistry | 2022

von Jiang, D. | Zhu, C. | He, Y. | +4

53

Polyaniline-MXene-coated carbon cloth as an anode for microbial fuel cells

enthalten in: Journal of solid state electrochemistry | 2022

von Jiang, D. | Zhu, C. | He, Y. | +4

54

Transmissibility of hand, foot, and mouth disease in 97 counties of China.

enthalten in: ResearchSquare.com | 2022

von Zhang, W. | Rui, J. | Cheng, X. | +13

55

Mitochondrial phylogenomics provides insights into the phylogeny and evolution of spiders (Arthropoda : Araneae)

enthalten in: Zoological research | 2022

von Li, M. | Chen, W. | Zhang, Q. | +5

56

Hypopituitary syndrome with pituitary crisis in a patient with traumatic shock : A case report

enthalten in: World journal of clinical cases | 2022

von Zhang, X. | Sun, Y.

57

Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia

enthalten in: Scientific reports | 2022

von Zhu, S. | Xing, C. | Li, R. | +8

58

Two Novel Co-Crystals of Naproxen : Comparison of Stability, Solubility and Intermolecular Interaction

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Xing, C. | Chen, T. | Wang, L. | +6

59

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Guo, W. | Liang, D. | Wang, P. | +11

60

Identifying optimal candidates for tumor resection among borderline and locally advanced pancreatic cancer : A population-based predictive model

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2022

von Lu, Z. | Shao, W. | Shi, X. | +6